Cyclins and cdks in development and cancer: a perspective.
about
Loading and unloading: orchestrating centrosome duplication and spindle assembly by Ran/Crm1MicroRNA mir-16 is anti-proliferative in enterocytes and exhibits diurnal rhythmicity in intestinal cryptsP. gingivalis accelerates gingival epithelial cell progression through the cell cyclep21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.Targeting CDK6 in cancer: State of the art and new insightsCell cycle progression by the repression of primary cilia formation in proliferating cellsBiogenesis and dynamics of mitochondria during the cell cycle: significance of 3'UTRs.A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesisSustained proliferation in cancer: Mechanisms and novel therapeutic targetsMithramycin exerts an anti-myeloma effect and displays anti-angiogenic effects through up-regulation of anti-angiogenic factorsTargeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma CellsSTAT3 regulates uterine epithelial remodeling and epithelial-stromal crosstalk during implantationMolecular mechanism of G1 arrest and cellular senescence induced by LEE011, a novel CDK4/CDK6 inhibitor, in leukemia cells.Mechanism of G1 arrest in the Drosophila eye imaginal disc.Endothelial alpha1-adrenoceptors regulate neo-angiogenesisDissect the Dynamic Molecular Circuits of Cell Cycle Control through Network Evolution Model.Silencing of Ether à go-go 1 by shRNA inhibits osteosarcoma growth and cell cycle progressionMutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemiaGenomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment.Cell cycle regulation by MicroRNAs in embryonic stem cellsClove extract inhibits tumor growth and promotes cell cycle arrest and apoptosis.Cell Cycle Deregulation in Ewing's Sarcoma PathogenesisLobaplatin arrests cell cycle progression in human hepatocellular carcinoma cells.Pin1 regulates centrosome duplication, and its overexpression induces centrosome amplification, chromosome instability, and oncogenesisMicroRNA-188 suppresses G1/S transition by targeting multiple cyclin/CDK complexesImpact of meriolins, a new class of cyclin-dependent kinase inhibitors, on malignant glioma proliferation and neo-angiogenesis.Genetic determinants at the interface of cancer and neurodegenerative disease.RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas.Effects and mechanisms of silibinin on human hepatoma cell lines.Silibinin inhibits human nonsmall cell lung cancer cell growth through cell-cycle arrest by modulating expression and function of key cell-cycle regulatorsHyperparathyroid genes: sequences reveal answers and questions.Cdk2-null mice are resistant to ErbB-2-induced mammary tumorigenesis.Transcription factor TFAP2C regulates major programs required for murine fetal germ cell maintenance and haploinsufficiency predisposes to teratomas in male miceInterferon-β produces synergistic combinatory anti-tumor effects with cisplatin or pemetrexed on mesothelioma cells.A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers.Regulation of CDK4Expression Analysis of Genes Involved in the RB/E2F Pathway in Astrocytic Tumors.MicroRNA-126 is down-regulated in human esophageal squamous cell carcinoma and inhibits the proliferation and migration in EC109 cell via PI3K/AKT signaling pathway.Germ cell pluripotency, premature differentiation and susceptibility to testicular teratomas in miceMMP-9 short interfering RNA induced senescence resulting in inhibition of medulloblastoma growth via p16(INK4a) and mitogen-activated protein kinase pathway.
P2860
Q24540385-024357D2-79E7-40DD-8350-8B7EC9354D43Q24610279-0D1AD3AC-F72C-40CB-A5DA-CD4DACCE48D6Q24650372-B1F8BB44-7AB0-49F3-AFA4-49AE56F5F06AQ25257047-9ED40163-215E-410D-BD74-24DF92C1E5A5Q26796499-6F073C53-5342-47A6-A5D2-B7E0FC610188Q27011729-270BA75A-8ACF-40BE-A239-8B806D931A61Q27303169-5A8BFC0B-E8F6-49CF-A213-FC33410A361DQ28296641-EEC60E5A-6F88-4245-A17B-C52211C04BB3Q28396388-A700888A-D4F8-437C-973B-3D6CAF521557Q28487743-FC2B4BFD-7016-43C6-AAE9-8A91648088B7Q28554501-59337092-5A44-4058-B365-980F1FB80D2EQ30409357-73C1245E-D64F-4D4E-964F-F800AABF5930Q32180070-18C4ADC0-4049-4441-8DD4-22070142AB15Q33276683-3D00E750-7A81-42D8-9DC6-02D84018CFF1Q33310598-FBF16C5A-5991-4D79-9832-D299CA45E346Q33561346-8F4BE03D-B58B-4F4D-8170-FA075CE33696Q33580439-C3F96F40-DBB9-4897-9DA7-55ED246C9417Q33774508-DF3052EA-8C04-468D-84DF-0DF89451FFA0Q33838679-0977E724-BA69-4B13-BA61-133AED0D2A80Q33951410-22AB6904-5D4A-4663-A544-9793DA2E8C34Q34044000-6051BCBE-70C9-4CD0-ACD5-BF8DA95E3FCBQ34260723-42995BB4-0774-4FBC-A70D-38EC239B7E30Q34335251-1155E199-B30F-41EA-80FD-8A5CFA254074Q34353633-51743B13-3C35-4F9D-AAEA-B435D59DB227Q34354797-277CE424-215A-4224-A1F2-8DFE09219BE3Q34359688-35FF5522-CBB4-4752-B339-365DF392D0E8Q34422582-25E1F431-797D-45A7-98B7-8DF9E7A805A0Q34439333-71DAE8F4-0105-4008-86B9-039C3AEF2068Q34583094-FC3AC59A-3B4D-404C-B060-EDB67B2FF4EBQ34627739-4DFBB109-5544-40CB-B405-D310CC9099A1Q34628063-A674AD5D-645F-48BE-A636-4FAC5439EC53Q34887604-59068EBE-197E-43E1-BCEF-802074466FF6Q34963433-43E5EDED-1974-430B-B9FC-40CFCA006294Q34974037-651639BD-610A-4DD5-805F-39F39449B608Q35099578-2F42815A-CCD4-44AF-991D-3F6931BDB8E7Q35147982-2A2CD62D-E19A-4F13-A870-1EE0F4B456D0Q35758932-AC2FE682-CF4E-471F-BB7B-DF988741B72AQ35853951-741B6DDE-0A50-4FEB-B3E3-51EEF0E95273Q35866515-349D8B4D-4BF6-4932-B81F-D146E2B5D77EQ35867473-1D006358-6253-445E-B764-001ACF509324
P2860
Cyclins and cdks in development and cancer: a perspective.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Cyclins and cdks in development and cancer: a perspective.
@ast
Cyclins and cdks in development and cancer: a perspective.
@en
type
label
Cyclins and cdks in development and cancer: a perspective.
@ast
Cyclins and cdks in development and cancer: a perspective.
@en
prefLabel
Cyclins and cdks in development and cancer: a perspective.
@ast
Cyclins and cdks in development and cancer: a perspective.
@en
P2093
P356
P1433
P1476
Cyclins and cdks in development and cancer: a perspective.
@en
P2093
Amit Deshpande
Peter Sicinski
Philip W Hinds
P2888
P304
P356
10.1038/SJ.ONC.1208618
P407
P577
2005-04-01T00:00:00Z